Recently, the Paris model was adapted to analyze the dynamics of neurofilament heavy chain (NfH) in pediatric patients with spinal muscular atrophy (SMA) and the effects of treatment (Paris et al., 2023). Here, NEFH is linked to spinal muscular atrophy.